8-K - Ovid Therapeutics Inc. - 8.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001628280-26-025926
Filing Date: 2026-04-20
Accepted: 2026-04-20 08:16:52
Documents: 11
Period of Report: 2026-04-17
Items: Item 8.01: Other Events
Ovid Therapeutics Inc. (Filer) CIK : 0001636651 (see all company filings) EIN. : 465270895 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 26873426 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | 8-K | ovid-20260420.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ovid-20260420.xsd | EX-101.SCH
3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ovid-20260420_lab.xml | EX-101.LAB
4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ovid-20260420_pre.xml | EX-101.PRE